These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31779779)

  • 21. Transanal Total Mesorectal Excision: International Registry Results of the First 720 Cases.
    Penna M; Hompes R; Arnold S; Wynn G; Austin R; Warusavitarne J; Moran B; Hanna GB; Mortensen NJ; Tekkis PP;
    Ann Surg; 2017 Jul; 266(1):111-117. PubMed ID: 27735827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Will MRI provide maps of lines of excision for rectal cancer?
    Radcliffe A; Brown G
    Lancet; 2001 Feb; 357(9255):495-6. PubMed ID: 11229665
    [No Abstract]   [Full Text] [Related]  

  • 23. Magnetic resonance imaging of rectal cancer.
    Dewhurst CE; Mortele KJ
    Radiol Clin North Am; 2013 Jan; 51(1):121-31. PubMed ID: 23182512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Downstaging after neoadjuvant therapy for rectal cancer modifies the planned original surgery].
    Scutari F; Tramutola G; Morlino A; Rossi MT; Manzione L; Rosati G; Sopranzi A
    G Chir; 2008; 29(6-7):277-80. PubMed ID: 18544264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are We Allowed to Limit Surgical Aggressiveness With Small Rectal Gastrointestinal Stromal Tumors?
    Fiore M; Raut CP; Gronchi A
    Ann Surg Oncol; 2017 May; 24(5):1153-1156. PubMed ID: 27900631
    [No Abstract]   [Full Text] [Related]  

  • 26. Tumor compactness improves the preoperative volumetry-based prediction of the pathological complete response of rectal cancer after preoperative concurrent chemoradiotherapy.
    Hsu CY; Wang CW; Kuo CC; Chen YH; Lan KH; Cheng AL; Kuo SH
    Oncotarget; 2017 Jan; 8(5):7921-7934. PubMed ID: 27974702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is it time to rethink the rule of total mesorectal excision? A prospective radiological and pathological study in 49 consecutive patients with mid-rectal cancer.
    Guedj N; Zappa M; Maggiori L; Bertin C; Hennequin C; Panis Y
    Colorectal Dis; 2016 Sep; 18(9):O314-21. PubMed ID: 27381492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ASO Author Reflections: From Overtreatment to Risk-Adjusted Therapy of Rectal Carcinoma.
    Junginger T
    Ann Surg Oncol; 2020 Feb; 27(2):428-429. PubMed ID: 31659643
    [No Abstract]   [Full Text] [Related]  

  • 29. Optimal management of small rectal cancers: TAE, TEM, or TME?
    Garcia-Aguilar J; Holt A
    Surg Oncol Clin N Am; 2010 Oct; 19(4):743-60. PubMed ID: 20883951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multimodal Assessments Are Needed for Restaging after Neoadjunvant Chemoradiation Therapy in Rectal Cancer Patients.
    Kye BH; Kim HJ; Kim G; Kim JG; Cho HM
    Cancer Res Treat; 2016 Apr; 48(2):561-6. PubMed ID: 26323642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of locally advanced rectal cancer.
    Klaassen RA; Nieuwenhuijzen GA; Martijn H; Rutten HJ; Hospers GA; Wiggers T
    Surg Oncol; 2004; 13(2-3):137-47. PubMed ID: 15572096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Session 4: What should we do for poor responders after chemoradiotherapy: bad biology or should the fight go on?
    Bhoday J; Glimelius B; Tait D; Glynne-Jones R; Adams R; Brown G
    Colorectal Dis; 2018 May; 20 Suppl 1():97-99. PubMed ID: 29878687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neoadjuvant treatment as a limiting factor to rectal ultrasonography].
    Fábián A; Bor R; Bálint A; Farkas K; Milassin Á; Rutka M; Tiszlavicz L; Nagy F; Molnár T; Szepes Z
    Orv Hetil; 2016 Jul; 157(30):1193-7. PubMed ID: 27452069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longer Intervals from Neoadjuvant Therapy to Rectal Cancer Surgery: The Clock is Ticking….
    Fernandez LM; Perez RO
    Ann Surg Oncol; 2019 Jul; 26(7):1957-1958. PubMed ID: 30945045
    [No Abstract]   [Full Text] [Related]  

  • 35. [Rectal cancer].
    Ulrich A; Büchler MW
    Chirurg; 2016 Jul; 87(7):551. PubMed ID: 27350123
    [No Abstract]   [Full Text] [Related]  

  • 36. Role of MRI for staging of rectal cancer.
    Jhaveri KS; Sadaf A
    Expert Rev Anticancer Ther; 2009 Apr; 9(4):469-81. PubMed ID: 19374600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiparametric MRI in rectal cancer.
    Gürses B; Böge M; Altınmakas E; Balık E
    Diagn Interv Radiol; 2019 May; 25(3):175-182. PubMed ID: 31063142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of laparoscopic and open surgery following pre-operative chemoradiation therapy for locally advanced lower rectal cancer.
    Kusano T; Inomata M; Hiratsuka T; Akagi T; Ueda Y; Tojigamori M; Shiroshita H; Etoh T; Shiraishi N; Kitano S
    Jpn J Clin Oncol; 2014 Apr; 44(4):305-10. PubMed ID: 24596335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and oncologic outcomes of totally robotic total mesorectal excision for rectal cancer: initial results in a center for minimally invasive surgery.
    Kim CN; Bae SU; Lee SG; Yang SH; Hyun IG; Jang JH; Cho BS; Park JS
    Int J Colorectal Dis; 2016 Apr; 31(4):843-52. PubMed ID: 26956581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significance of MRI in rectal carcinoma therapy optimization - correlation of preoperative T- and N-staging with definitive histopathological findings.
    Danihel L; Danihel L; Rajcok M; Mosna K; Belan V; Varga I; Schnorrer M
    Neoplasma; 2019 May; 66(3):494-498. PubMed ID: 30793609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.